There is an urgent and unmet need to advance our ability to translate genetic studies of
psychiatric disorders into clinically actionable information, which could transform diagnostics …

We aim to systematically explore the potential genetic correlations between five major
psychiatric disorders and gestational ages. Genome‐wide association study (GWAS) …

Cell type-specific pathway-based polygenic risk scores (PRSs) may better inform disease
biology and improve the precision of PRS-based clinical prediction. For microRNA-137 …

Background Attention-deficit/hyperactivity disorder (ADHD) is highly heritable, but little is
known about the relative effects of transmitted (ie, direct) and nontransmitted (ie, indirect) …

Social isolation has been linked to a range of psychiatric issues, but the behavioral
component that drives it is not well understood. Here, a genome-wide associations study …

Background Chemokines and their receptors regulate inflammatory processes in major
depressive disorder (MDD). Here, we characterize the expression pattern of the CC …

The integration of multi‐omics information (eg, epigenetics and transcriptomics) can be
useful for interpreting findings from genome‐wide association studies (GWAS). It has been …

Background Treatment-resistant schizophrenia affects approximately 30% of individuals with
the disorder. Clozapine is the medication of choice in treatment-resistant schizophrenia, but …

Susceptibility to schizophrenia is mediated by genetic and environmental risk factors.
Maternal immune activation by infections during pregnancy is hypothesized to be a key …

Background Although studies suggest that concentrations of omega-3 and omega-6 fatty
acids are lower in individuals with schizophrenia, evidence for beneficial effects of fatty acid …